Establish a single source of truth by seamlessly integrating reference data, deep data, patient data, and HCP access metrics through a common data architecture (CDA). This clean and harmonized data foundation is what allows AI to move beyond basic analytics to predictive, actionable intelligence that field teams can actually trust.
³Ô¹Ï±¬ÁÏ’s common data architecture (CDA) is an open and freely available industry standard for life sciences operational data. It provides a simple, universal set of data structures for entities like healthcare professionals (HCPs) and healthcare organizations (HCOs). CDA is important because it standardizes how software and data products communicate, eliminating data friction, increasing interoperability, and speeding up analytics.
Master data management (MDM) in pharma is a systematic process for creating and maintaining a single, consistent, and accurate source of information for critical business entities like customers, products, and organizations. An effective MDM strategy eliminates data redundancy, reduces inconsistencies, and provides a reliable foundation for decision-making and regulatory compliance.
A data-driven approach improves customer engagement by providing a deeper understanding of customer behaviors and preferences. By analyzing data from various sources, you can personalize content and choose the right channels to deliver messages that resonate with each customer, building trust and driving more meaningful interactions.
Yes. Integrating medical insights with commercial data provides a complete 360-degree view of the customer. By connecting ³Ô¹Ï±¬ÁÏ Link and ³Ô¹Ï±¬ÁÏ Medical Insights with ³Ô¹Ï±¬ÁÏ Vault CRM, commercial teams can compliantly understand KOLs¡¯ and HCPs¡¯ scientific interests and sentiment, ensuring that the transition from medical education to commercial engagement is seamless and coordinated.
AI is only as good as the data powering it. A unified foundation eliminates fragmented silos, preventing ¡®AI hallucinations¡¯ and ensuring that agentic AI models have the reliable context they need to act. Without a clean, unified layer, AI-driven recommendations lose the trust of the field teams who rely on them.
Agentic-ready data is high-quality, governed data that is structured specifically for AI consumption. While 96% of biopharma leaders believe their current data is not AI-ready, achieving this state requires both harmonization and ongoing governance. This creates the common language needed for AI Agents to autonomously handle tasks like pre-call planning or medical inquiry summaries with accuracy.
³Ô¹Ï±¬ÁÏ ensures compliance through a ‘privacy-by-design’ approach. Our data solutions are built natively into the secure Vault Platform, ensuring that all AI-ready datasets ¡ª including patient and prescriber data ¡ª adhere to global regulations like GDPR and the EU AI Act. This architecture ensures that your proprietary commercial data is never leaked into public models, maintaining total data sovereignty.
³Ô¹Ï±¬ÁÏ helps biopharmas deepen customer insights through the power of connected data and software ¡ª connecting sales, marketing, and medical teams on a single, AI-embedded platform with a unified customer database.
Designed for seamless integration with ³Ô¹Ï±¬ÁÏ Commercial Cloud applications, this approach provides a comprehensive 360-degree view of the stakeholder, allowing teams to move from raw data to decisive action instantly. By creating a unified foundation, ³Ô¹Ï±¬ÁÏ fast-tracks the path to AI-driven engagement and intelligent workflows, ensuring every customer interaction is grounded in real-time, cross-functional intelligence.
No. While ³Ô¹Ï±¬ÁÏ OpenData is the industry standard for commercial reference data (HCP, HCO, and affiliations), ³Ô¹Ï±¬ÁÏ OpenData Clinical provides a dedicated, compliant data foundation specifically for clinical research sites and investigators. Both solutions are built on ³Ô¹Ï±¬ÁÏ¡¯s common data architecture (CDA), meaning they share a universal ID for healthcare providers. This allows a single investigator to be tracked seamlessly from trial participation in clinical operations through to their scientific impact in a medical or commercial CRM. By unifying clinical and commercial data, biopharmas eliminate manual matching, prevent duplicate records, and gain a 360-degree view of the stakeholder across the entire product lifecycle.
You can read more about , attend ³Ô¹Ï±¬ÁÏ Commercial Summit, or contact your ³Ô¹Ï±¬ÁÏ account team for more information.
